Mr. Young brings over 20 years of finance and capital markets experience, an extensive background in financial planning and operations, management and strategy, and a deep knowledge of the life sciences sector. Mr. Young most recently served as CFO, Treasurer and Secretary at Juniper Pharmaceuticals, Inc., where he played an instrumental role in Juniper’s acquisition by Catalent. Prior to that, Mr. Young served as CFO and Treasurer of OvaScience, a global fertility company focused on new treatment options for women. Mr. Young was previously the CFO and Treasurer of Transmedics, a developer of medical devices for the maintenance and transport of organs between donors and recipients. Before that, he served as CFO and Treasurer at Lantheus Medical Imaging, where he led and managed multiple public debt offerings.
Mr. Young began his career holding various positions of increasing responsibility in finance at Critical Therapeutics, PerkinElmer, Inc. and PriceWaterhouseCoopers LLP. Mr. Young holds a Bachelor of Science in Business Administration from Georgetown University